Nanoformulated water-soluble paclitaxel to enhance drug efficacy and reduce hemolysis side effect.

about

Nanoformulated water-soluble paclitaxel to enhance drug efficacy and reduce hemolysis side effect.

Item

http://www.wikidata.org/entity/Q50875323

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Nanoformulated water-soluble p ...... reduce hemolysis side effect.

@en

Nanoformulated water-soluble p ...... reduce hemolysis side effect.

@nl

type

Item

label

Nanoformulated water-soluble p ...... reduce hemolysis side effect.

@en

Nanoformulated water-soluble p ...... reduce hemolysis side effect.

@nl

prefLabel

Nanoformulated water-soluble p ...... reduce hemolysis side effect.

@en

Nanoformulated water-soluble p ...... reduce hemolysis side effect.

@nl

P1476

Nanoformulated water-soluble p ...... reduce hemolysis side effect.

@en

P2093

Beihua Kong

http://www.w3.org/2001/XMLSchema#string

Jason P Acker

http://www.w3.org/2001/XMLSchema#string

Jie Chen

http://www.w3.org/2001/XMLSchema#string

Lingxuan Wei

http://www.w3.org/2001/XMLSchema#string

Prabir Patra

http://www.w3.org/2001/XMLSchema#string

Quanrong Gu

http://www.w3.org/2001/XMLSchema#string

Weiting Gu

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Microtubules as a target for anticancer drugs

Nanocarriers as an emerging platform for cancer therapy

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation.

Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization.

Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity.

Nanotechnology in drug delivery and tissue engineering: from discovery to applications

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.

Red blood cell hemolysis during processing.

Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules.

The formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cells

P304

66-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0885328217708458

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28504558

http://www.w3.org/2001/XMLSchema#string